title: Risk factors for early hemorrhagic complications after endovascular coiling of ruptured intracranial aneurysms.
abstract: OBJECTIVE
  The risk factors of early hemorrhagic complications after endovascular coiling are not well-known. We identified the factors affecting early hemorrhagic complications, defined as any expansion or appearance of hemorrhage shown by head CT in the initial 48 hours after coiling.
  
  
  METHODS
  We retrospectively reviewed a series of 93 patients who underwent coiling for a ruptured saccular aneurysm between 2006 and 2012 at our hospital.
  
  
  RESULTS
  Five patients showed early hemorrhagic complications, and all involved an expansion of the existing intracerebral hematoma immediately after coiling. The associated risk factors were accompanying intracerebral hemorrhage at onset (P < .001), postoperative antiplatelet therapy (P < .001), and thromboembolic complications (P = .044). In the accompanying intracerebral hemorrhage group, the associated risk factors were postoperative antiplatelet therapy (P = .044) and earlier initiation of coiling (9.8 ± 6.5 versus 28.1 ± 24.0 hours, P = .023). Early hemorrhagic complications were significant risk factors for worse clinical outcome (modified Rankin Scale, 2.02 ± 2.21 versus 4.4 ± 2.30, P = .022). None of the 93 patients showed further hemorrhage after the initial 48 hours after coiling.
  
  
  CONCLUSIONS
  The accompanying intracerebral hemorrhage at onset, thromboembolic complications, postoperative antiplatelet therapy, and earlier initiation of coiling were the risk factors for early hemorrhagic complications.
authors.affiliation: From the Department of Neuroendovascular Treatment, Shiroyama Hospital, Osaka, Japan. tsuyoshi@ya2.so-net.ne.jp.
authors.forename: T
authors.initials: T
authors.lastname: Ohta
authors.affiliation: From the Department of Neuroendovascular Treatment, Shiroyama Hospital, Osaka, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Murao
authors.affiliation: From the Department of Neuroendovascular Treatment, Shiroyama Hospital, Osaka, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Miyake
authors.affiliation: From the Department of Neuroendovascular Treatment, Shiroyama Hospital, Osaka, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Takemoto
authors.affiliation: From the Department of Neuroendovascular Treatment, Shiroyama Hospital, Osaka, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Nakazawa
mesh_terms: D000328:Adult; D000368:Aged; D017542:Aneurysm, Ruptured / Q000628:therapy*; D001807:Blood Vessel Prosthesis; D002543:Cerebral Hemorrhage / Q000453:epidemiology / Q000209:etiology; D004621:Embolization, Therapeutic / Q000009:adverse effects* / Q000379:methods; D057510:Endovascular Procedures / Q000009:adverse effects* / Q000295:instrumentation; D005260:Female; D006406:Hematoma / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D002532:Intracranial Aneurysm / Q000601:surgery* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology*; D012189:Retrospective Studies; D012307:Risk Factors